ESCRS - Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy ;
ESCRS - Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy ;

Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy

Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy
Leigh Spielberg
Leigh Spielberg
Published: Friday, September 23, 2016
euretina%ef%80%a2escrs-main_richard_1910“Because of frequent development or progression of cataract after vitrectomy for such indications as macular hole or epiretinal membrane, combining vitrectomy and phacoemulsification in one operation may be indicated, especially in elderly patients,” said Gisbert Richard MD, Germany. Speaking to a combined EURETINA/ESCRS session in Copenhagen yesterday, Dr Richard emphasized the difference between cataract progression in post-vitrectomy patients above the age of 60 years, in which the incidence approaches 100%, and those younger than 40 years, who have very low risk of cataract after vitrectomy.   “Phaco-vitrectomy has developed into a very safe and effective combined procedure which often improves visibility of the posterior segment during surgery, and also spares patients a second procedure later in time,” said Dr Richard.   Indeed, surgical time might not necessarily increase as compared to vitrectomy alone, as complete vitrectomy is technically simpler in a pseudophakic eye, due to the eliminated risk of lens touch during shaving of the vitreous base. Dr Richard recommends creating a long corneal or corneo-scleral tunnel that tolerates the intraocular pressure increases experienced during vitrectomy. “The tunnel should be at least 3.0mm,” he said.   “Femtolaser-assisted phaco can offer advantages in patients with endothelial dystrophy,” he added, although complicated technical equipment and additional costs might limit this development.   Dr Richard’s study of combined phaco-vitrectomy in 230 patients operated for epiretinal membrane indicated good visual outcome for what has since become routine procedure for many surgeons.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;